Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

Launched by NATIONAL CANCER CENTRE, SINGAPORE · Jun 17, 2016

Keywords

ClinConnect Summary

The IMPACT Project is a clinical trial designed to help people with solid tumors find the best cancer treatment options by examining the unique characteristics of their tumors. The goal is to use this detailed information to better match patients with available clinical trials that might be suitable for them. This could lead to more personalized and effective treatment plans for individuals facing cancer.

To participate in this study, you need to have a confirmed diagnosis of a solid tumor and be able to provide a sample of your tumor tissue for testing. You should also be in good enough health to participate in treatment and understand the information provided about the study. The trial is currently looking for participants aged 76 and older, and there are no restrictions based on gender. If you join the trial, you can expect to undergo some tests to analyze your tumor, which can help guide your treatment options moving forward.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed histological diagnosis of solid tumor
• • Suitable for systematic treatment and clinical trials
• • ECOG (Eastern cooperative oncology group) performance status \< 2
• • Able to provide tumor tissue for molecular profiling
• • Able to understand and sign the informed consent form
• Exclusion Criteria:
• • None